Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
TQC2731 injection is a humanized monoclonal antibody that targets Thymic Stromal Lymphopoietin (TSLP), blocks the TSLP pathway, and inhibits the production of downstream cytokines, thereby exerting anti-inflammatory effects. The purpose of this study is to evaluate the efficacy and safety of TQC2731 injection in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).
Epistemonikos ID: e89c0000180675aa3fdd498af6b1bc69c45b7d03
First added on: Aug 07, 2025